The 20 Best Choriocarcinoma Doctors near New Hyde Park, NY

Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Orchiectomy, and Nephrectomy.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

Joph Steckel is a Urologist in Lake Success, New York. Dr. Steckel is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Dr. Gilbert is a Professor of Urology at the Hofstra North Shore LIJ School of Medicine and Adjunct Clinical Professor of Urology and Reproductive Medicine at Weill Cornell Medical College. He is also the Director of Reproductive and Sexual Medicine at the Smith Institute for Urology of the Northwell Health System. Dr. Gilbert has authored over 100 publications and is recognized as an expert in Male Fertility and Urologic Ultrasound. He is passionate about Urologic education and has organized training programs in microsurgery and urologic ultrasound as well as lectured locally, nationally and internationally.Dr. Gilbert completed his medical degree in 1983 at Cornell University Medical College and Urology Residency at the New York Hospital Cornell Medical Center. Prior to that he completed a Doctorate (Ph.D.) at the New York Medical College followed by postdoctoral work in Renal Physiology supported by the New York Heart Association in the Department of Physiology at Cornell University Medical College.Dr. Gilbert s private practice for the past 28 years has specialized in male reproductive and sexual medicine and surgery including male prosthetic surgery. He is an experienced microsurgeon having performed over a 1000 microsurgical procedures including vasectomy reversals, microsurgical varicocele ligation and microsurgical testicular sperm retrieval. Dr. Gilbert is the Medical and Laboratory Director of New York Cryo, one of the few long term reproductive tissue banks for sperm, oocytes and embryos in the region. He has also gained national prominence for his use of Holistic approaches for the treatment of chronic Urologic problems.Dr. Gilbert is certified by the American Board of Urology and the American Board of Medical Acupuncture. He is a fellow of both the American College of Surgeons and The American Academy of Medical Acupuncture. He serves as a reviewer for many Urological, Reproductive Medicine and Complementary Medicine Journals.He is married with two children and four grandchildren. He enjoys golfing and is an instrument rated pilot.bgilbert@gmail.comhttp://www.brucegilbertmd.com. Dr. Gilbert is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Peyronie Disease, Spermatogenesis Arrest, Varicocele, and Sertoli Cell-Only Syndrome.

Gary Goldberg is a Urologist in Manhasset, New York. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Reconstructive Urology Surgery.

Michael Levine is a Urologist in New Hyde Park, New York. Dr. Levine is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Perirenal Abscess, and Ureteroscopy.

Frank Tomao is an Oncologist and an Internal Medicine provider in New Hyde Park, New York. Dr. Tomao is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer.

Dimitri Kessaris is a Urologist in Manhasset, New York. Dr. Kessaris is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Urinary Incontinence.

Mitchell Efros is a Urologist in New Hyde Park, New York. Dr. Efros is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Perirenal Abscess, and Hormone Replacement Therapy (HRT).

Brian Mcnelis is an Oncologist in New Hyde Park, New York. Dr. Mcnelis is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Familial Colorectal Cancer, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Louis Faiella is a Urologist in Mineola, New York. Dr. Faiella is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Boils, and Ureteroscopy.

Joseph Jamal is a Urologist in Garden City, New York. Dr. Jamal is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Ureterocele, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Nephrectomy, and Reconstructive Urology Surgery.

Mary O'keeffe is a Hematologist and an Oncologist in Mineola, New York. Dr. O'keeffe is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Familial Prostate Cancer, Bone Marrow Aspiration, and Endoscopy.

Alexander Hindenburg is a Hematologist in Mineola, New York. Dr. Hindenburg is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Endoscopy.

Anne Renteria is a Hematologist in Mineola, New York. Dr. Renteria is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Guido Dalbagni is a Urologist in New York, New York. Dr. Dalbagni is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy. Dr. Dalbagni is currently accepting new patients.

Arlyn Apollo is an Oncologist in Uniondale, New York. Dr. Apollo is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, and Muscle Invasive Bladder Cancer. Dr. Apollo is currently accepting new patients.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy.